ArticleHeliyon2025
Identification of anti-c, E alloantibodies with autoantibodies mimicking anti-c, E alloantibodies.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Autoantibodies mimicking alloantibodies (referred to as mimicking antibodies) are a type of specific antibody that reacts with all red blood cells, but exhibits a stronger reaction with red blood cells expressing the target antigens. This study aimed to explore immunohematologic methods for identifying mimicking antibodies, autoantibodies and alloantibodies, and to formulate safe transfusion strategies based on the results. Methods: ABO, Rh blood types and direct antiglobulin test were determined using the tube saline method. Antibody detection and identification were performed using tube saline and anti-human globulin microcolumn gel method with two sets of panel red blood cells. The specificity of antibodies was confirmed through absorption elution test, antibody dilution and titer integral method. Results: The study identified the presence of both anti-c and anti-E alloantibodies as well as anti-c and anti-E mimicking antibodies in patient samples. Based on these findings, suitable A-type CCDee donors can be selected for the patient, while avoiding both mimicking antibodies and alloantibodies. Conclusion: When mimicking antibodies, autoantibodies and alloantibodies are present in patients, either separately or simultaneously, antibody identification can be challenging. Accurate determination of the type and specificity of antibodies is essential for developing safe transfusion strategies in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.